In this week's Homerun Slides, getting blood pressure to goal and the benefits of beta blockers.
Read More »Yearly Archives: 2018
International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #125: Beta-Cell Mass and Function in Human Type 2 Diabetes Part 1
Insulin-producing beta-cells are the predominant endocrine cell type in pancreatic islets, comprising 50 – 80% of islet cells. Studies with autoptic samples, organ donor specimens, and surgical cases have found that beta-cell mass in the human pancreas may vary from 0.6 to 2.1 g, with beta-cell volume and area (relative to the pancreatic tissue) ranging from 1.1 – 2.6% and 0.6 – 1.6%, respectively.
Read More »Dual-Hormone System May Lower Time in Hypoglycemia in T1DM
Lowest mean time in hypoglycemia seen with dual-hormone closed-loop system during exercise period
Read More »May 12, 2018
When new drugs come to market, they are either a better version of an established class, a new delivery method, or a whole new class with a steep learning curve. This week, in our two lead articles, we look at some new compounds and some new delivery systems that could …
Read More »Four New Drugs Waiting for Approval That Can Change the Diabetes Landscape (Part 1)
Two of the four exciting treatment options currently being trialed could change the way the disease is treated long term.
Read More »Four New Drugs Waiting for Approval That Can Change The Diabetes Landscape (Part 2)
New exciting treatment options currently being trialed could change the way the disease is treated long term.
Read More »Death After Lower Limb Amputation
Study answers questions of risk difference based on demographics.
Read More »Can Patients with Diabetes Take Beta-Blockers? Should They?
Medication use may be associated with increased risk of mortality.
Read More »Vitamin D Link to Diabetes Risk
New study assesses increased risk of type 2, most beneficial method of raising vitamin D levels.
Read More »Which Diabetes Treatment Is Most Effective In Keeping Your Patients Alive?
SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compared in reducing mortality and cardiovascular events in patients with type 2.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.